English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/52280
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer

AuthorsBermudo, Raquel; Abia, David ; Benitez, Daniel; Carrió, Anna; Vilella, Ramón; Ortiz, Ángel R. ; Thomson, Timothy M. ; Fernández, Pedro L.
Issue Date2010
PublisherWiley-Blackwell
CitationAnnals of the New York Academy of Sciences 1210: 17-24 (2010)
AbstractDespite its high incidence as the second most common tumor in males worldwide, primary prostate cancer has been associated with few recurrent chromosomal gains and deletions that are consistent across various studies. Few studies have explored how chromosomal alterations are coupled to abnormal gene expression. Here, we review the major genomic aberrations associated with prostate cancer and describe how detailed transcriptional and computational analyses allowed us to discover a recurrent chromosomal gain in a small region on chromosome 17. Fluorescent in situ hybridization confirmed the presence of a copy number gain in 17q25.3 in tumor-associated preneoplastic lesions of the prostate, 65% of primary tumors, and metastatic samples. These results suggest the involvement of this gain at all steps of prostate cancer progression. © 2010 New York Academy of Sciences.
URIhttp://hdl.handle.net/10261/52280
DOI10.1111/j.1749-6632.2010.05780.x
Identifiersdoi: 10.1111/j.1749-6632.2010.05780.x
issn: 1749-6632
Appears in Collections:(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.